Schnell-Inderst Petra, Iglesias Cynthia P, Arvandi Marjan, Ciani Oriana, Matteucci Gothe Raffaella, Peters Jaime, Blom Ashley W, Taylor Rod S, Siebert Uwe
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Eduard Wallnoefer Center I, Hall i.T., Austria.
Department of Health Sciences, University of York, Heslington, UK.
Health Econ. 2017 Feb;26 Suppl 1:46-69. doi: 10.1002/hec.3474.
Evaluation of clinical effectiveness of medical devices differs in some aspects from the evaluation of pharmaceuticals. One of the main challenges identified is lack of robust evidence and a will to make use of experimental and observational studies (OSs) in quantitative evidence synthesis accounting for internal and external biases. Using a case study of total hip replacement to compare the risk of revision of cemented and uncemented implant fixation modalities, we pooled treatment effect estimates from OS and RCTs, and simplified existing methods for bias-adjusted evidence synthesis to enhance practical application. We performed an elicitation exercise using methodological and clinical experts to determine the strength of beliefs about the magnitude of internal and external bias affecting estimates of treatment effect. We incorporated the bias-adjusted treatment effects into a generalized evidence synthesis, calculating both frequentist and Bayesian statistical models. We estimated relative risks as summary effect estimates with 95% confidence/credibility intervals to capture uncertainty. When we compared alternative approaches to synthesizing evidence, we found that the pooled effect size strongly depended on the inclusion of observational data as well as on the use bias-adjusted estimates. We demonstrated the feasibility of using observational studies in meta-analyses to complement RCTs and incorporate evidence from a wider spectrum of clinically relevant studies and healthcare settings. To ensure internal validity, OS data require sufficient correction for confounding and selection bias, either through study design and primary analysis, or by applying post-hoc bias adjustments to the results. © 2017 The Authors. Health Economics published by John Wiley & Sons, Ltd.
医疗器械临床有效性的评估在某些方面与药品评估有所不同。已确定的主要挑战之一是缺乏有力证据,且不愿在考虑内部和外部偏倚的定量证据综合中利用实验性和观察性研究(OS)。通过全髋关节置换的案例研究来比较骨水泥型和非骨水泥型植入固定方式的翻修风险,我们汇总了来自OS和随机对照试验(RCT)的治疗效果估计值,并简化了现有的偏倚调整证据综合方法以增强实际应用。我们利用方法学和临床专家进行了一次启发式练习,以确定对影响治疗效果估计的内部和外部偏倚程度的信念强度。我们将偏倚调整后的治疗效果纳入广义证据综合中,计算了频率学派和贝叶斯统计模型。我们将相对风险估计为具有95%置信/可信区间的汇总效应估计值,以捕捉不确定性。当我们比较综合证据的替代方法时,我们发现汇总效应大小强烈依赖于观察性数据的纳入以及偏倚调整估计值的使用。我们证明了在荟萃分析中使用观察性研究来补充RCT并纳入来自更广泛临床相关研究和医疗保健环境的证据的可行性。为确保内部有效性,OS数据需要通过研究设计和初步分析,或通过对结果应用事后偏倚调整,对混杂和选择偏倚进行充分校正。© 2017作者。《健康经济学》由约翰·威利父子有限公司出版。